Bank Julius Baer & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,897
| Closed | -$52.2K | – | 522 |
|
|
2024
Q1 | $52.2K | Sell |
1,897
-10
| -0.5% | -$275 | ﹤0.01% | 465 |
|
|
2023
Q4 | $58.1K | Sell |
1,907
-691
| -27% | -$21.1K | ﹤0.01% | 471 |
|
|
2023
Q3 | $82K | Sell |
2,598
-7,102
| -73% | -$224K | ﹤0.01% | 430 |
|
|
2023
Q2 | $396K | Sell |
9,700
-1,351
| -12% | -$55.2K | ﹤0.01% | 361 |
|
|
2023
Q1 | $412K | Buy |
11,051
+1,600
| +17% | +$59.7K | ﹤0.01% | 362 |
|
|
2022
Q4 | $330K | Sell |
9,451
-1,495
| -14% | -$52.2K | ﹤0.01% | 376 |
|
|
2022
Q3 | $613K | Buy |
10,946
+1,503
| +16% | +$84.2K | ﹤0.01% | 316 |
|
|
2022
Q2 | $489K | Sell |
9,443
-2,481
| -21% | -$128K | ﹤0.01% | 343 |
|
|
2022
Q1 | $867K | Sell |
11,924
-1,600
| -12% | -$116K | 0.01% | 297 |
|
|
2021
Q4 | $1.6M | Buy |
+13,524
| New | +$1.6M | 0.01% | 297 |
|
|
2021
Q1 | – | Sell |
-6,563
| Closed | -$357K | – | 867 |
|
|
2020
Q4 | $357K | Buy |
+6,563
| New | +$357K | ﹤0.01% | 497 |
|